Holen Sie sich die Stockscreener-App
4.69
7.08%
0.31
Handel nachbörslich:
4.72
0.03
+0.64%
Schlusskurs vom Vortag:
$4.38
Offen:
$4.41
24-Stunden-Volumen:
150.41K
Relative Volume:
0.62
Marktkapitalisierung:
$55.28M
Einnahmen:
$52.29M
Nettoeinkommen (Verlust:
$-73.52M
KGV:
-7.1061
EPS:
-0.66
Netto-Cashflow:
$-100.45M
1W Leistung:
-2.49%
1M Leistung:
+5.39%
6M Leistung:
-7.31%
1J Leistung:
-47.60%
1-Tages-Spanne:
$4.37
$4.7294
1-Wochen-Bereich:
$4.27
$4.80
52-Wochen-Spanne:
$3.61
$11.09
Precision Biosciences Inc Stock (DTIL) Company Profile
Firmenname
Precision Biosciences Inc
Sektor
Branche
Telefon
919-314-5512
Adresse
302 EAST PETTIGREW STREET, DURHAM, NC
Vergleichen Sie DTIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
4.69 | 51.27M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Eingeleitet | Guggenheim | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-09 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Fortgesetzt | BTIG Research | Buy |
| 2020-04-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Stifel | Buy |
| 2020-02-25 | Eingeleitet | William Blair | Outperform |
| 2019-08-09 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-22 | Eingeleitet | Barclays | Overweight |
| 2019-04-22 | Eingeleitet | Goldman | Buy |
| 2019-04-22 | Eingeleitet | JP Morgan | Overweight |
| 2019-04-22 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten
How Precision BioSciences Inc. stock performs during market volatilityROI King Stock Alerts - newsyoung.net
Precision BioSciences Reports Significant Quarterly Loss - TipRanks
Layoff Tracker: Bicycle, Tune, Iovance, Precision Downsize to Conserve Cash - BioSpace
Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates - MSN
Applying Elliott Wave Theory to Precision BioSciences Inc.Algorithmic Forecast for Swing Trading Picks - Newser
Is Precision BioSciences Inc. stock entering bullish territorySafe Investment Ideas with Growth Upside - Newser
Precision BioSciences: Q2 Earnings Snapshot - Connecticut Post
Precision BioSciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Precision BioSciences Reports Second Quarter 2025 Financial Resu - GuruFocus
Precision BioSciences Reports Breakthrough: 69% HBV Reduction and FDA Recognition for DMD Program - Stock Titan
Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B - Pipelinereview
Positive Outlook for Precision BioSciences Amid Promising Clinical Trial Data and Strategic Advancements - TipRanks
Precision BioSciences Reports Promising Phase 1 Trial Results - TipRanks
Precision BioSciences Announces Phase 1 Safety and Efficacy for - GuruFocus
Precision BioSciences reports positive data for hepatitis B gene therapy By Investing.com - Investing.com Canada
Using R and stats models for Precision BioSciences Inc. forecastingPredictive AI Engine for Smart Investing - Newser
Precision BioSciences Inc expected to post a loss of $1.57 a shareEarnings Preview - TradingView
Precision BioSciences to Report Second Quarter 2025 Results on August 7, 2025 - BioSpace
Precision BioSciences: A Strategic Play in the Gene Editing Revolution Amid Q2 Momentum and Regulatory Breakthroughs - AInvest
Precision BioSciences Inc. Stock Analysis and ForecastRemarkable growth - Jammu Links News
Is Precision BioSciences Inc. stock overvalued or undervaluedGet exclusive market insights for better trading - Jammu Links News
What institutional investors are buying Precision BioSciences Inc. stockInvest in stocks with long-term growth potential - Jammu Links News
What is Precision BioSciences Inc. company’s growth strategyRealize consistent double-digit growth - Jammu Links News
Does Precision BioSciences Inc. stock perform well during market downturnsCapitalize on high-growth stocks early - Jammu Links News
When is Precision BioSciences Inc. stock expected to show significant growthMaximize profits with strategic stock selection - Jammu Links News
Using data filters to optimize entry into Precision BioSciences Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
What are the latest earnings results for Precision BioSciences Inc.Achieve rapid portfolio appreciation today - Jammu Links News
What catalysts could drive Precision BioSciences Inc. stock higher in 2025Capitalize on high-growth stocks early - Jammu Links News
Is it the right time to buy Precision BioSciences Inc. stockUnprecedented market success - Jammu Links News
Published on: 2025-08-03 13:05:53 - Jammu Links News
What are analysts’ price targets for Precision BioSciences Inc. in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Should I hold or sell Precision BioSciences Inc. stock in 2025Real Time Tracker For Fast Growth - Jammu Links News
Precision Biosciences shares fall 2.11% intraday as Illumina reports Q2 revenue drop. - AInvest
Published on: 2025-07-29 15:58:11 - metal.it
Why Precision BioSciences Inc. stock attracts strong analyst attentionFast Return Equity Trade Forecast Points to Small Caps - metal.it
Precision BioSciences Inc. Stock Lags Behind Sector BenchmarksReal Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru
What are the technical indicators suggesting about Precision BioSciences Inc.Explosive capital appreciation - Jammu Links News
How does Precision BioSciences Inc. generate profit in a changing economyBuild wealth steadily with smart trading - Jammu Links News
What are Precision BioSciences Inc. company’s key revenue driversBuild wealth steadily with expert advice - Jammu Links News
Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):